Correction: Evaluation of CYP2D6 and Efficacy of Tamoxifen and Raloxifene in Women Treated for Breast Cancer Chemoprevention: Results from the NSABP P1 and P2 Clinical Trials

In this article (Clin Cancer Res 2011;17:6944–51), which was published in the November 1, 2011, issue of Clinical Cancer Research (1), in Table 3, under CYP2D6*4, the number of Wt/Wt patients was mislabeled. This should be 1,116 as opposed to 116. All analyses and reported results were based upon the correct number of wild-type alleles for CYP2D6 *4 (1,116). Therefore, the results remain unchanged. The authors regret this error.